Founder effect for a 26-bp deletion in the RFXANK gene in North African major histocompatibility complex class II-deficient patients belonging to complementation group B

Immunogenetics

Volumn 51, Issue 4-5, 2000, Pages 261-267

  Wiszniewski, Wojciech ^a,c   Fondaneche, Marie Claude ^a   Lambert, Nathalie ^a   Masternak, Krzysztof ^b   Picard, Capucine ^a   Notarangelo, Luigi ^e   Schwartz, Klaus ^e   Bal, Jerzy ^c   Reith, Walter ^b   Alcaide, Catherine ^d   De Saint Basile, Geneviève ^a   Fischer, Alain ^a   Lisowska Grospierre, B ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c INSTITUTE OF MOTHER AND CHILD   (Poland)

^d INSERM   (France)

^e NONE

Author keywords

Bare lymphocyte syndrome; Founder effect; MHC class II deficiency; MHC class II expression; RFXANK gene mutations

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TRANSCRIPTION FACTOR;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BASE PAIRING; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; FAMILIAL DISEASE; FEMALE; GENE DELETION; GENE EXPRESSION; GENE LOCUS; GENETIC COMPLEMENTATION; HAPLOTYPE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; MUTATION RATE; NORTH AFRICA; PRIORITY JOURNAL; TRANSACTIVATION; TRANSCRIPTION REGULATION;

EID: 0034072751     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002510050619     Document Type: Article

References (20)

1. Barrat FJ, Auloge L, Pastural E, Dufourcq-Lagelouse R, Vilmer E, Cant AJ, Weissenbach J, Le Paslier D, Fischer A, De Saint Basile G (1996) Genetic and physical mapping of the Chediak-Higashi syndrome on chromosome 1q42-43. Am J Hum Gen 59:625-632
2. Bork P (1993) Hundreds of ankytin-like repeats in functionally diverse proteins: mobile modules that cross phyla horizontally? Proteins Struct Funct Genet 17:363-374
3. Dib C, Fauré S, Fizames C, Samson D, Drouot N, Vignal A, Millasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J (1996) A comprehensive genetic map of the human genome based on 5,2964 microsatellites. Nature 380:152-154
4. Durand B, Sperisen P, Emery P, Barras E, Zufferey M, Mach B, Reith W (1997) RFXAP, a novel subunit of the RFX DNA binding complex is mutated in MHC class II deficiency. EMBO J 16:1045-1055
5. Fondaneche M-C, Villard J, Wiszniewski W, Etzioni A, Le Deist F, Peijnenburg A, Casanova J-L, Reith W, Mach B, Fischer A, Lisowska-Grospierre B (1998) Genetic and molecular definition of complementation group D in MHC class II deficiency. Hum Mol Gen 7:879-885
6. Griscelli C, Fischer A, Grospierre B, Durandy A, Bremard C, Charron D, Vilmer E, Virelizier J-L (1984) Clinical and immunological aspects of combined immunodeficiency with defective expression of HLA antigens. Excerpta Medica, Amsterdam
7. Griscelli C, Lisowska-Grospierre B, Mach B (1993) Combined immunodeficiency with defective expression in MHC class II genes. In: Rosen FS, Seligman M (eds) Immunodeficiencies. Harwood, Chur, pp 141-154
8. Hume CR, Lee JS (1989) Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes results from distinct mutations in trans-acting factors. Hum Immunol 26:288-309
9. Klein C, Lisowska-Grospierre B, LeDeist F, Fischer A, Griscelli C (1993) Major histocompatibility complex class II deficiency: clinical manifestations, immunologic features, and outcome. J Pediatr 123:921-929
10. Lin J-H, Makris A, McMahon C, Bear SE, Patriotis C, Prasad VR, Brent R, Golemis EA, Tsichilis PN (1999) The ankyrin repeat-containing adaptor protein Tvl-1 is a novel substrate and regulator of Raf-A. J Biol Chem 274:14706-14715
11. Lisowska-Grospierre B, Fondaneche M-C, Rols M-P, Griscelli C, Fischer A (1994) Two complementation groups account for most cases in inherited MHC class II deficiency. Hum Mol Genet 3:953-958
12. Louis-Plence P, Moreno CS, Boss JM (1997) Formation of a RFX-X2BP-NF-Y multiprotein complex on the conserved regulatory regions of HLA class II genes. J. Immunol 159:3899-3909
13. Masternak K, Barras E, Zufferet M, Conrad B, Corthals G, Aebersold R, Sanchez J-C, Hochstrasser DF, Mach B, Reith W (1998) The majority of MHC class II deficient patients are affected in a novel RFX-associated transactivator containing ankyrin repeats. Nat Genet 20:3:273-277
14. Moreno CS, Rogers EM, Brown JA, Boss JM (1997) Regulatory factor X, a bare lymphocyte syndrome transcripton factor, is a multimeric phosphoprotein complex. J Immunol 158:5841-5848
15. Nagarajan U, Louis-Plence P, DeSandro A, Nilsen R, Bushley A, Boss JM (1999) RFX-B is the gene responsible for the most common cause of the bare lymphocyte syndrome, an MHC class II immunodeficiency. Immunity 10:153-162
16. Reith W, Satola S, Herrero-Sanchez C, Amaldi I, Lisowska-Grospierre B, Griscelli C, Hadam MR, Mach B (1988) Congenital immunodeficiency with a regulatory defect in MHC class II gene expression lacks a specific HLA-DR promoter binding protein, RF-X. Cell 53:897-906
17. Reith W, Kobr M, Emery P, Durand B, Siegrist C-A, Mach B (1994a) Cooperative binding between factors RFX and X2bp to the X and X2 boxes of MHC class II promoters. J Biol Chem 269:20020-20025
18. Reith W, Siegrist CA, Durand B, Barras E, Mach B (1994b) Function of major histocompatibility complex class II promoters requires cooperative binding between factors RFX and NF-Y. Proc Natl Acad Sci USA 91:554-558
19. Steimle V, Otten LA, Zufferey M, Mach B (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75:135-146
20. Steimle V, Durand B, Barras E, Zufferey M, Hadam MR, Mach B, Reith W (1995) A novel DNA-binding regulatory factor is mutated in primary MHC class II deficiency (bare lymphocyte syndrome). Genes Dev 9:1021-1032